236 related articles for article (PubMed ID: 15978773)
1. Post-marketing surveillance system for drugs in pregnancy--15 years experience of ENTIS.
Schaefer C; Hannemann D; Meister R
Reprod Toxicol; 2005; 20(3):331-43. PubMed ID: 15978773
[TBL] [Abstract][Full Text] [Related]
2. Pregnancy outcome after exposure to ranitidine and other H2-blockers. A collaborative study of the European Network of Teratology Information Services.
Garbis H; Elefant E; Diav-Citrin O; Mastroiacovo P; Schaefer C; Vial T; Clementi M; Valti E; McElhatton P; Smorlesi C; Rodriguez EP; Robert-Gnansia E; Merlob P; Peiker G; Pexieder T; Schueler L; Ritvanen A; Mathieu-Nolf M
Reprod Toxicol; 2005; 19(4):453-8. PubMed ID: 15749258
[TBL] [Abstract][Full Text] [Related]
3. Vitamin K antagonists and pregnancy outcome. A multi-centre prospective study.
Schaefer C; Hannemann D; Meister R; Eléfant E; Paulus W; Vial T; Reuvers M; Robert-Gnansia E; Arnon J; De Santis M; Clementi M; Rodriguez-Pinilla E; Dolivo A; Merlob P
Thromb Haemost; 2006 Jun; 95(6):949-57. PubMed ID: 16732373
[TBL] [Abstract][Full Text] [Related]
4. Isotretinoin exposure and pregnancy outcome: an observational study of the Berlin Institute for Clinical Teratology and Drug Risk Assessment in Pregnancy.
Schaefer C; Meister R; Weber-Schoendorfer C
Arch Gynecol Obstet; 2010 Feb; 281(2):221-7. PubMed ID: 19444462
[TBL] [Abstract][Full Text] [Related]
5. Adverse effects of prenatal methimazole exposure.
Di Gianantonio E; Schaefer C; Mastroiacovo PP; Cournot MP; Benedicenti F; Reuvers M; Occupati B; Robert E; Bellemin B; Addis A; Arnon J; Clementi M
Teratology; 2001 Nov; 64(5):262-6. PubMed ID: 11745832
[TBL] [Abstract][Full Text] [Related]
6. Using observational cohort data for studying drug effects on pregnancy outcome--methodological considerations.
Schaefer C; Ornoy A; Clementi M; Meister R; Weber-Schoendorfer C
Reprod Toxicol; 2008 Sep; 26(1):36-41. PubMed ID: 18588969
[TBL] [Abstract][Full Text] [Related]
7. Drug safety in pregnancy: utopia or achievable prospect? Risk information, risk research and advocacy in Teratology Information Services.
Schaefer C
Congenit Anom (Kyoto); 2011 Mar; 51(1):6-11. PubMed ID: 21158950
[TBL] [Abstract][Full Text] [Related]
8. The effectiveness of Teratology Information Services (TIS).
Hancock RL; Koren G; Einarson A; Ungar WJ
Reprod Toxicol; 2007 Feb; 23(2):125-32. PubMed ID: 17184969
[TBL] [Abstract][Full Text] [Related]
9. The safety of calcium channel blockers during pregnancy: a prospective, multicenter, observational study.
Weber-Schoendorfer C; Hannemann D; Meister R; Eléfant E; Cuppers-Maarschalkerweerd B; Arnon J; Vial T; Rodriguez-Pinilla E; Clementi M; Robert-Gnansia E; De Santis M; Malm H; Dolivo A; Schaefer C
Reprod Toxicol; 2008 Sep; 26(1):24-30. PubMed ID: 18585452
[TBL] [Abstract][Full Text] [Related]
10. Selection bias in Teratology Information Service pregnancy outcome studies.
Johnson KA; Weber PA; Jones KL; Chambers CD
Teratology; 2001 Aug; 64(2):79-82. PubMed ID: 11460258
[TBL] [Abstract][Full Text] [Related]
11. Pregnancy outcome following maternal exposure to statins: a multicentre prospective study.
Winterfeld U; Allignol A; Panchaud A; Rothuizen LE; Merlob P; Cuppers-Maarschalkerweerd B; Vial T; Stephens S; Clementi M; De Santis M; Pistelli A; Berlin M; Eleftheriou G; Maňáková E; Buclin T
BJOG; 2013 Mar; 120(4):463-71. PubMed ID: 23194157
[TBL] [Abstract][Full Text] [Related]
12. Does the average drug exposure in pregnant women affect pregnancy outcome? A comparison of two approaches to estimate the baseline risks of adverse pregnancy outcome.
Wacker E; Navarro A; Meister R; Padberg S; Weber-Schoendorfer C; Schaefer C
Pharmacoepidemiol Drug Saf; 2015 Apr; 24(4):353-60. PubMed ID: 25644395
[TBL] [Abstract][Full Text] [Related]
13. Ethical approval for multicenter cohort studies on drug exposure during pregnancy: A survey among members of the European Network of Teratology Information Services (ENTIS).
Winterfeld U; Weber-Schöndorfer C; Schaefer C; von Elm E; Buclin T
Reprod Toxicol; 2018 Sep; 80():68-72. PubMed ID: 29913205
[TBL] [Abstract][Full Text] [Related]
14. Pregnancy outcome after gestational exposure to the new macrolides: a prospective multi-center observational study.
Bar-Oz B; Diav-Citrin O; Shechtman S; Tellem R; Arnon J; Francetic I; Berkovitch M; Ornoy A
Eur J Obstet Gynecol Reprod Biol; 2008 Nov; 141(1):31-4. PubMed ID: 18760873
[TBL] [Abstract][Full Text] [Related]
15. Multiple sclerosis, immunomodulators, and pregnancy outcome: a prospective observational study.
Weber-Schoendorfer C; Schaefer C
Mult Scler; 2009 Sep; 15(9):1037-42. PubMed ID: 19692433
[TBL] [Abstract][Full Text] [Related]
16. The estimation of human teratogenic/fetotoxic risk of exposures to drugs on the basis of Hungarian experience: a critical evaluation of clinical and epidemiological models of human teratology.
Czeizel AE
Expert Opin Drug Saf; 2009 May; 8(3):283-303. PubMed ID: 19505262
[TBL] [Abstract][Full Text] [Related]
17. Postmarketing surveillance for human teratogenicity: a model approach.
Chambers CD; Braddock SR; Briggs GG; Einarson A; Johnson YR; Miller RK; Polifka JE; Robinson LK; Stepanuk K; Lyons Jones K
Teratology; 2001 Nov; 64(5):252-61. PubMed ID: 11745831
[TBL] [Abstract][Full Text] [Related]
18. The safety of cetirizine during pregnancy. A prospective observational cohort study.
Weber-Schoendorfer C; Schaefer C
Reprod Toxicol; 2008 Sep; 26(1):19-23. PubMed ID: 18571373
[TBL] [Abstract][Full Text] [Related]
19. The reproductive effects of beta interferon therapy in pregnancy: a longitudinal cohort.
Boskovic R; Wide R; Wolpin J; Bauer DJ; Koren G
Neurology; 2005 Sep; 65(6):807-11. PubMed ID: 16186517
[TBL] [Abstract][Full Text] [Related]
20. Providing information regarding exposures in pregnancy: a survey of North American Teratology Information Services.
Hancock RL; Ungar WJ; Einarson A; Goodstadt M; Koren G
Reprod Toxicol; 2008 Apr; 25(3):381-7. PubMed ID: 18423962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
